14 Recruiting Generalized Myasthenia Gravis Phase 3 Clinical Trials
Active phase 3 studies for generalized myasthenia gravis enrolling across the USA. Verify eligibility and contact site coordinators.
All Generalized Myasthenia Gravis studiesPhase 3 Studies for Generalized Myasthenia Gravis
A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis
📍 HonorHealth Neurology 2018 — Scottsdale, Arizona
View Study & Checklist ➔A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
📍 HonorHealth Neurology - Bob Bove Neuroscience Institute — Scottsdale, Arizona
View Study & Checklist ➔Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis
📍 Research Site — Orange, California
View Study & Checklist ➔Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravulizumab in Pediatric Participants With Generalized Myasthenia Gravis
📍 Research Site — Los Angeles, California
View Study & Checklist ➔Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis
📍 Site Number -1022 — Phoenix, Arizona
View Study & Checklist ➔A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.
📍 Honor Health Research Institute — Scottsdale, Arizona
View Study & Checklist ➔A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
📍 Neuromuscular Research Center — Phoenix, Arizona
View Study & Checklist ➔Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
📍 Arizona Neuroscience Research, LLC — Phoenix, Arizona
View Study & Checklist ➔A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
📍 Mg0014 50168 — Chicago, Illinois
View Study & Checklist ➔Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
📍 Site Number - 1056 — Huntsville, Alabama
View Study & Checklist ➔Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis
📍 Ann and Robert H Lurie Children's Hospital of Chicago - Main Hospital — Chicago, Illinois
View Study & Checklist ➔A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
📍 Carolinas HealthCare System Neurosciences Institute - Neurology — Charlotte, North Carolina
View Study & Checklist ➔A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
📍 HonorHealth Neurology - Bob Bové Neuroscience Institute — Scottsdale, Arizona
View Study & Checklist ➔PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis
📍 Research Site — Washington D.C., District of Columbia
View Study & Checklist ➔